NeurIPS 2025:生物学的Transformer时刻——基因工程与生物技术新闻
NeurIPS 2025: Biology’s Transformer Moment - Genetic Engineering and Biotechnology News
生物技术与制药领域的最新动态
NeurIPS 2025: Biology’s Transformer Moment - Genetic Engineering and Biotechnology News
10x Genomics $TXG Shares Bought by Jump Financial LLC - MarketBeat
NeurIPS 2025: Altos Labs Wins Generalist Prize at Arc’s Virtual Cell Challenge - Genetic Engineering and Biotechnology News
Is 10x Genomics Stock Built to Withstand More Downside? - Trefis
Life Sciences Tools & Services Stocks Q3 Earnings: 10x Genomics (NASDAQ:TXG) Firing on All Cylinders - TradingView
Life Sciences Tools & Services Stocks Q3 Earnings: 10x Genomics (NASDAQ:TXG) Firing on All Cylinders - Markets Financial Content
Life Sciences Tools & Services Stocks Q3 Earnings: 10x Genomics (NASDAQ:TXG) Firing on All Cylinders - Finviz
10x Genomics (TXG) Is Down 5.5% After Morgan Stanley Downgrade Has The Bull Case Changed? - simplywall.st
10x Genomics (TXG): Assessing Valuation After a 36% One-Month Share Price Rebound - simplywall.st
10x Genomics (TXG): Assessing Valuation After a 36% One-Month Share Price Rebound - simplywall.st
Why 10x Genomics Inc. stock appeals to analysts - July 2025 Reactions & Low Risk Entry Point Guides - Newser
Rethinking 10x Genomics (TXG): Is the Recent Share Price Rebound Already Pricing In Its Growth Potential? - Yahoo Finance
Rethinking 10x Genomics (TXG): Is the Recent Share Price Rebound Already Pricing In Its Growth Potential? - Yahoo Finance UK
Russell Investments Group Ltd. Increases Stock Position in 10x Genomics $TXG - MarketBeat
Stocks To Watch: 10x Genomics Sees Relative Strength Rating Rise To 91 - MSN
Next Generation Sequencing Library Preparation Market - openPR.com
3 Unprofitable Stocks with Questionable Fundamentals - Yahoo Finance
Human Single-Cell Multi-Omics Market Set for Rapid Growth, - openPR.com
10x Genomics Comments on Second UPC Preliminary Injunction Decis - GuruFocus
TXG: Morgan Stanley Downgrades 10x Genomics, Raises Price Target | TXG Stock News - GuruFocus